Archivos de cardiologia de Mexico · 2025
Utilidad del sistema de puntuación UK-BCIS CHIP Score para la estratificación del riesgo en procedimientos coronarios complejos.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
García-Arias Mario R, Pérez-González Alberto, Guareña-Casillas Jorge A, Garza-Vergara José L, Mondaca-García Óscar A, Medina-Godinez Laura I, Jauregui-Plascencia Luis, Salazar-Vela David, Rosas-Martínez Manuel A, Islas-Rodríguez Juan P, Baltazar-Cordero Eloína C, Cabrales-Escobar Ivan E, Ramos-Aguas Diego A, Camacho-Sánchez Alexandra
Аннотация
OBJECTIVE: To apply the UK-BCIS CHIP Score system to identify patients who meet the criteria for complex percutaneous coronary intervention, thereby enabling the development of a personalized therapeutic strategy.
METHOD: Retrospective cohort of patients with chronic coronary syndrome, unstable angina, and non-ST-segment elevation myocardial infarction who underwent percutaneous coronary intervention between January 2018 and March 2024 at a tertiary care hospital in Mexico. A univariate survival analysis was performed, represented by a Kaplan-Meier curve. A Cox regression model was used to estimate cardiovascular mortality with statistically significant angiographic variables.
RESULTS: The median survival follow-up in patients with a score of 0 was 77 months (95% CI: 76-78); with a score of 1-2, 66 months (95% CI: 62-69); with a score of 3-4, 39 months (95% CI: 34-43); and with a score ≥ 5, 12 months (95% CI: 7-16). C-index: 0.86. The Cox regression model showed that a higher UK-BCIS CHIP Score (HR: 2.533; 95% CI: 2.013-3.186) was significantly associated with an increased risk of cardiovascular mortality and one-year hospital readmission.
CONCLUSIONS: Appropriate stratification using the UK-BCIS CHIP Score was independently associated with an increased risk of one-year cardiovascular mortality and hospital readmission after percutaneous coronary intervention.
METHOD: Retrospective cohort of patients with chronic coronary syndrome, unstable angina, and non-ST-segment elevation myocardial infarction who underwent percutaneous coronary intervention between January 2018 and March 2024 at a tertiary care hospital in Mexico. A univariate survival analysis was performed, represented by a Kaplan-Meier curve. A Cox regression model was used to estimate cardiovascular mortality with statistically significant angiographic variables.
RESULTS: The median survival follow-up in patients with a score of 0 was 77 months (95% CI: 76-78); with a score of 1-2, 66 months (95% CI: 62-69); with a score of 3-4, 39 months (95% CI: 34-43); and with a score ≥ 5, 12 months (95% CI: 7-16). C-index: 0.86. The Cox regression model showed that a higher UK-BCIS CHIP Score (HR: 2.533; 95% CI: 2.013-3.186) was significantly associated with an increased risk of cardiovascular mortality and one-year hospital readmission.
CONCLUSIONS: Appropriate stratification using the UK-BCIS CHIP Score was independently associated with an increased risk of one-year cardiovascular mortality and hospital readmission after percutaneous coronary intervention.